Pfizer And Moderna Reportedly Expanding Covid Vaccine Studies Of Children To Better Understand Rare Side Effects

Pfizer and Moderna are expanding the sizes of their Covid-19 vaccine trials in children ages five to 11,Monday, characterizing the move as a precautionary measure to better understand rare side effects—including heart inflammation problems—that have turned up in some young people.Multiple anonymous sources toldthat vaccine makers are moving to expand their ongoing clinical trials at the request of the Food and Drug Administration .

The agency reportedly indicated the size and scope of the current studies were inadequate to detect the rare side effects of myocarditis and pericarditis that have been identified in a very small number of coronavirus vaccine recipients under 30. last month showing around 500 of the 1,200 Americans who developed heart inflammation issues after receiving mRNA vaccines were under the age of 30.

This amounts to less than 13 cases per one million second doses administered of these diseases, which—marked by symptoms like chest pain and shortness of breath—typically clear up within a few weeks, but in a small number of cases can be chronic. What To Watch For It’s currently unclear how expanding the size of the trials will impact the timeline for getting these vaccines formally approved for use in children. The FDA

earlier this month it expects the emergency authorization for Covid-19 vaccines in children under 12 to come in early to midwinter. it found a “likely association” between a rare heart inflammatory condition in young people and the coronavirus vaccine, though the reported cases were minute compared with total inoculations and the risk of getting the diseases are even greater among those with Covid-19.

Awesome!

“Rare” 😂 😂 Millions and millions of people are reporting side effects and even dying.

Studies? You mean testing, right? They're testing the gene therapy on kids.

nice

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

WSJ News Exclusive | Covid-19 Pill Race Heats Up as Japanese Firm Vies With Pfizer, MerckJapan’s Shionogi has started human trials for a once-a-day drug designed to neutralize the coronavirus in less than a week as Pfizer and Merck carry out later-stage tests. There are already ones out there: azythromicine plus Invermectin. Why keep denying it? 🙏 Better approach
Source: WSJ - 🏆 98. / 63 Read more »

Mixed AstraZeneca-Pfizer shot boosts COVID antibody level - studyA mixed vaccination of first AstraZeneca (AZN.L) and then a Pfizer (PFE.N) COVID-19 shot boosted neutralizing antibody levels by six times compared with two AstraZeneca doses, a study from South Korea showed. Somebody outhere is trying to save AstraZeneca vaccine as many people refuse it. I just mix it today 😅 💉💉
Source: Reuters - 🏆 2. / 97 Read more »

Pfizer and Moderna to expand size of vaccine studies in 5- to 11-year-oldsPfizer and Moderna are expanding the size of their COVID-19 vaccine studies in children ages 5 to 11, according to a new report. We require new Nuremberg trials IG Farben Trial The United States of America vs. Carl Krauch, et al., also known as the IG Farben Trial, was the sixth of the twelve trials for war crimes the U.S. authorities held in their occupation zone in Germany after the end of World War II. Experiments On Children & You Vote!🤦🏽‍♂️🤦🏽‍♂️😷😷 Hugo Ernesto Osorio Chavez Arrested
Source: ABC - 🏆 471. / 51 Read more »

Pfizer And Moderna To Expand Studies Of Vaccines In 5- To 11-Year-OldsAt the request of the FDA, the vaccine makers are expanding their trials with young children, seeking to better detect very rare heart issues.
Source: HuffPostParents - 🏆 414. / 53 Read more »

Pfizer And Moderna To Expand Studies Of Vaccines In 5- To 11-Year-OldsAt the request of the FDA, the vaccine makers are expanding their trials with young children, seeking to better detect very rare heart issues.
Source: HuffPostWomen - 🏆 27. / 68 Read more »